The completion of the trial allows Lilly to seek regulatory approval and potentially launch the next-generation drug in 2027 as it competes with Novo Nordisk in the obesity treatment market
Common areas affected after GLP-1 weight loss: Face & Neck: Jowls, sagging cheeks, loose neck skin Breasts: Loss of volume and firmness Upper Arms: Bat wings from skin hanging under the triceps Abdomen & Flanks: Skin overhang or apron belly Buttocks & Thighs: Flattened or deflated contours The Problem of Skin Excess After Massive Weight Loss Whether weight loss is achieved through medication, lifestyle changes, or bariatric surgery, the skin often does not shrink back to match the new body contours
According to KFF, both GLP-1 prescriptions and gross spending (Medicaid spending before drug rebates are applied) on GLP-1s have increased rapidly within state Medicaid programs in the past few years
What we handle for patients: Eligibility screening and risk review before starting therapy Dose titration with check-ins to manage tolerability Injection training, storage, and sharps guidance Sideeffect playbook (nausea, constipation, hydration cues) Simple nutrition and activity guidance aligned to your plan Coordination for prescriptions and follow-up scheduling Our Complete Process for GLP-1 Weight Loss in Olympia, WA A predictable care map keeps progress steady and budgets under control
200 units of 200 mcg each